Accumulation and oligomerization of amyloid-beta (Aβ) peptides have been known to be a potent cause of neurodegenerative diseases such as Alzheimer's disease (AD). To expand the possibilities of preventing AD, we investigated the effects of resveratrol dimers, gnetin C and ε-viniferin, on Aβ 1-42 (Aβ42) production and the reduced cell viability observed after Aβ42 treatment (monomers, 10 μM) in cultured SH-SY5Y human neuroblastoma cells. Among them, addition of gnetin C (20 μM) into the media reduced Aβ42 production most efficiently. Gnetin C suppressed the expression of β-site amyloid precursor protein-cleaving enzyme-1 (
ε-viniferin (standard ≥ 98.0% [HPLC] , #226-02021), dimethyl sulfoxide (DMSO), sodium dodecyl sulphate (SDS) and the enzyme-linked immunosorbent assay (ELISA) kit for Aβ42 (Human/Rat βAmyloid (1-42) ELISA Kit Wako, High-Sensitive) were obtained from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Human Aβ42 monomer was from Peptide Institute, Inc. (Ibaraki, Japan). The CellQuanti-MTT™ assay kit was from BioAssay Systems (Hayward, CA, USA). The NucleoSpin ® RNA II total RNA isolation kit was from Macherey-Nagel GmbH & Co. KG (Düren, Germany). An iScript™ Advanced cDNA synthesis kit and SsoAdvanced™ Universal SYBR ® Green Supermix solution for reverse transcription-quantitative polymerase chain reaction (RT-qPCR) were obtained from Bio-Rad Laboratories, Inc. (Hercules, CA, USA). Oligonucleotide primers for qPCR were custom synthesized by Fasmac/Greiner Japan (Atsugi, Japan). The bicinchoninic acid (BCA™) protein assay kit was from Pierce Cell Culture. SH-SY5Y human neuroblastoma cells (ECACC No. 94030304) were obtained from the European Collection of Authenticated Cell Cultures (Porton Down, UK), and cultured in DMEM/F12 containing GlutaMAX™-I supplemented with 10% FBS (21) . Once the cells were 80% confluent, they were used for experimental purpose; immediately, the medium was replaced with fresh Advanced DMEM/F12 containing GlutaMAX™-I supplemented with 3% FBS. In experiments with biophenols toxicity as a result of its higher hydrophobicity, thus, leading to faster oligomerization and aggregation (3). Aβ 1-43 (Aβ43) is also frequently detected in AD brains (31, 39) , and it is reported to be more neurotoxic than Aβ42 and can promote Aβ42 polymerization (22, 30) ; however, physiological Aβ43 production in vitro is nearly undetectable (40) and its deteriorative effect on cell viability is comparable to Aβ42 (8) .
A hypothetical model of dynamic biomarker for AD suggests that a substantial Aβ load in the brain occurs before the appearance of clinical symptoms (34) . This preclinical phase of AD provides a critical opportunity for preventive intervention. In this context, we previously found that carnosic acid, a phenolic diterpene compound in the labiate herb rosemary, reduces Aβ production by inducing TACE expression in both human neuron and astrocyte models (21, 40) . We also demonstrated that in a human neuron model, carnosic acid and rebamipide, a gastrointestinal protective drug, attenuate the Aβ-induced apoptosis by reducing the intracellular accumulation of Aβ oligomers (8, 22) , and that rebamipide enhances the expression of MMP-14 (8) .
Resveratrol is a red grape-derived biophenol and is well known to have cytoprotective functions (9, 23) , in particular, against neurotoxic factors such as Aβ peptides (13, 20, 28) . Some resveratrol oligomers appear to have biological activities that are superior to monomeric resveratrol (6) . However, the neuroprotective functions of resveratrol dimers have not been well known (26, 27) . In the present study, we focused on two resveratrol dimers (19) , gnetin C isolated from melinjo (Gnetum gnemon L.) and ε-viniferin from grapevines; and examined the effects of these dimers on Aβ42 production and Aβ42-induced neurotoxicity using cultured human neuroblastoma cells as a model of human neurons. Western blot analysis. Cellular proteins were detected by Western blotting, as described previously (8, 22) . Briefly, cells cultured in a 35 mm-diameter dish were washed twice with ice-cold 20 mM phosphatebuffered saline (PBS, pH 7.4). The cells were then lysed in 50 μL of Laemmli reducing sample buffer with shorter pulses of ultrasonication for 30 s and then incubated on ice for 30 min. Lysates were centrifuged at 10,000 × g for 20 min at 4°C, and the supernatants were transferred to fresh tubes. After the BCA protein assay, aliquots of the solutions containing 5, 10 or 20 μg protein were mixed with 6 × loading buffer and boiled for 6 min. The samples were subjected to electrophoresis on a 10-20% SDSpolyacrylamide gel, and proteins were transferred onto PVDF membranes. The membranes were blocked by incubating in Tris-bufferd saline with Tween 20 (TBS-T, pH 7.4; 50 mM Tris-HCl, 250 mM NaCl, and 0.1% Tween-20) containing 1% nonfat dry milk for 1 h at room temperature. The membranes were then incubated with an anti-Aβ 1-16, anti-MMP-14, or anti-APP (1 : 1000) antibody overnight at 4°C, followed by a third incubation with the appropriate secondary antibodies (HRP-conjugat-(resveratrol or its dimers), cells were pretreated with the biophenol for 1 h prior to the addition of Aβ42. Aβ42 and the biophenols were dissolved in DMSO; the maximum final concentration of DMSO in culture medium was 1.1%, and control cells were treated with vehicle alone.
MATERIALS AND METHODS

Reagents
Cell viability. Cell viability was measured by using a CellQuanti-MTT™ assay kit according to the manufacturer's protocol with slight modifications (22) . SH-SY5Y cells were cultured in 96-well culture plates at 4 × 10 4 cells per well in 100 μL of medium. The MTT reagent (15 μL) was then added per well, and the cells were incubated for an additional 4 h. Formazan crystals only produced by living cells were solubilized by adding 100 μL/well of solubilizer (10% SDS, 3.2 mM HCl) and the plates were placed overnight at 37°C. The absorbance (A570) of the resulting colored solution was measured with a microplate reader (iMark, Bio-Rad). Each experiment was performed in triplicate.
ELISA. Cell culture supernatants were mixed with 0.2% BSA and 0.075% CHAPS to minimize the loss of Aβ42 by adhesion to storage tubes. Aliquots of the samples were stored at −80°C until further use. The levels of Aβ42 in the cell-conditioned medium and whole cell lysates were determined using an ELISA kit and an iMark/Bio-Rad microplate reader (22, 40) .
RT-qPCR. Total RNA was extracted from cells, and single-strand cDNA was synthesized using an iScript™ Advanced cDNA synthesis kit for RT-qPCR (8) . A CFX96™ Real-Time PCR System (Bio-Rad) was ADAM10  TTTGATGATGGCGTACTTGG  AGTTTGTCCCCAGATGTTGC  TACE  TTGGTGGTAGCAGATCATCG  CTGGGAGAGCCAACATAAGC  BACE1  CCGGCGGGAGTGGTATTATG  GCAAACGAAGGTTGGTGGT  PS1  GGTAAAGCCTCAGCAACAGC  AAACAAGCCCAAAGGTGATG   NEP  GCCTCAGCCGAACCTACAAG  AATTTGCACAACGTCCTCAAGTT  IDE  GCCGAAGCCTTGTCTCAACT  CAAATAGGCCATGTTACAGTGCAA  ECE1  GACGCCGATGAGAAGTTCATG  GCAAAACTTCCAGCGAGGAA  MMP-14  CACTGCCTACGAGAGGAAGG  TCCCTTCCCAGACTTTGATG 18S rRNA ACTCAACACGGGAAACCTCA AACCAGACAAATCGCTCCAC
Abbreviations used: ADAM, a disintegrin and metalloproteinase; TACE, tumor necrosis factor-α-converting enzyme (also termed as ADAM17); BACE1, β-site APP-cleaving enzyme-1; PS1, presenilin-1; NEP, neprilysin; IDE, insulin-degrading enzyme; ECE1, endothelin-converting enzyme 1; MMP, matrix metalloproteinase; MMP-14, also termed as membrane type-1 MMP (MT1-MMP).
34%, respectively; and was comparable to the cells treated with 10 or 20 μM of resveratrol, which reduced Aβ42 secretion by 21 or 33%, respectively.
Gnetin C suppresses BACE1 expression and enhances MMP-14 expression
Based on the aforementioned results, we decided to investigate the gnetin C-mediated changes in expression of genes that potentially affect Aβ levels (Fig. 3) .
As for secretases, we found that gnetin C treatment significantly suppressed, at the transcriptional level, the expression of the β-secretase, BACE1, for both 6 ed anti-rabbit, or anti-mouse IgG, 1 : 5000) for 1 h at room temperature. The immunoreactive bands were detected by an enhanced chemiluminescence (ECL) detection system. The same blot was then reprobed with an anti-β-actin antibody (1 : 5000).
Densitometric quantification. The integrated optical density of the immunoreactive band was quantified using ImageJ 1.49i software (National Institute of Health, Bethesda, MD, USA) and was normalized to the β-actin band density.
RNA interference (RNAi).
Cells were transfected with the target gene siRNA or nonsilencing control siRNA (8) , using the Lipofectamine™ RNAiMAX transfection reagent, according to the manufacturer's protocol. After 48 h, the cells were washed, and fresh Advanced DMEM/F12 containing GlutaMAX™-I media supplemented with 3% FBS was added. The cells were then treated with gnetin C alone or with both gnetin C and Aβ42 for 24 h.
Statistics. Values are expressed as mean ± SD, and statistical significance was analyzed by the unpaired two-tailed t-test or one-way analysis of variance (ANOVA). Significance was assigned to a probability (P) value less than 0.05.
RESULTS
Safety tests of gnetin C and ε-viniferin
We first evaluated the no adverse effect level of two resveratrol dimers (gnetin C and ε-viniferin) on cell viability in SH-SY5Y human neuroblastoma cells, using the MTT assay (Fig. 1) . After treatment for 48 h, ε-viniferin did not affect the cell viability up to 100 μM (also resveratrol, up to 50 μM), but gnetin C decreased the cell viability at 30 μM or higher. Therefore, we mainly used the 20 μM dose of gnetin C or ε-viniferin as a condition to test our hypothesis in the following experiments.
Gnetin C and ε-viniferin lower Aβ42 production
We next examined the effects of gnetin C and ε-viniferin on the endogenous production of Aβ monomers in cultured SH-SY5Y cells (Fig. 2) . The specificity of the ELISA kit allowed us to accurately determine the level of secreted Aβ42. Untreated control cells constitutively released Aβ42 into the media for 24 h. In contrast, gnetin C treatment (10 or 20 μM) effectively lowered Aβ42 secretion by 49 or 63%, respectively. ε-viniferin (10 or 20 μM) moderately decreased Aβ42 production by 21 or The integrated optical density of the protein band in (B and C) was quantified using ImageJ 1.49i and was normalized to that of actin.
and 24 h (Fig. 3A) . Gnetin C did not have much remarkable effects on mRNA expressions of ADMA10 (a constitutive α-secretase), TACE (an inducible α-secretase) and presenilin-1 (a core part in γ-secretase complex). Next, we focused on the other enzymes related to Aβ decomposition, i.e., NEP, IDE, ECE1 and MMP-14 ( Fig. 3B) . It was eye-catching that MMP-14 mer (Aβ trimer) was lowered by gnetin C and resveratrol by 51 and 52%, respectively. At the same time, gnetin C did not reduce but elevate the levels of both intracellular and extracellular Aβ42 monomers (Fig. 6C ).
Gnetin C enhances MMP-14 expression even in the presence of Aβ42
Since we found that gnetin C alone enhances the expression of MMP-14 in SH-SY5Y cells (Fig. 3B and Fig. 4A-C) , we examined whether gnetin C upregulates MMP-14 expression under the same condition as shown in Fig. 6 . As shown in Fig. 7 , gnetin C exactly enhanced the expression of MMP-14 in the cells; this increase was observed in the presence of 10 μM Aβ42 after 6 h (at an mRNA level) and 24 h (at mRNA and protein levels). Here again, resveratrol did not change MMP-14 expression.
DISCUSSION
In the present study, we have examined resveratrol dimers, gnetin C and ε-viniferin, as possible preventive measures against neurotoxicity induced by Aβ accumulation. This is the first study to reveal that gnetin C suppressed the level of Aβ42 production and improved the cell viability of human neuroblastoma cells treated with Aβ42.
Our results demonstrate that gnetin C has an efficiently suppressive effect on Aβ42 production compared to resveratrol and ε-viniferin. Uniquely, gnetin C consistently down-regulates β-secretase (BACE1) mRNA was eminently induced by gnetin C for both 6 and 24 h, although the others were decreased for 24 h (IDE, for 6 h also). Incidentally, another resveratrol dimer, ε-viniferin, moderately increased the expressions of TACE, IDE and ECE1 for 24 h, showing the same or analogous expression patterns to those of resveratrol.
Knockdown of MMP-14 suppresses the gnetin C-induced protein expression
To confirm that the gnetin C-induced upregulation of MMP-14 expression levels are dependent on gnetin C treatment, we performed gene knockdown of MMP-14 by siRNA and examined the protein level (Fig. 4) . Both gnetin C-induced and constitutive expressions of MMP-14 were clearly inhibited, at both the mRNA (Fig. 4A ) and protein ( Fig. 4B and 4D ) levels, by the addition of respective MMP-14 siRNA. In contrast, gnetin C and/or the siRNA did not affect APP protein expression ( Fig. 4C and 4E ). These results confirmed that gnetin C moderately but significantly enhanced MMP-14 protein expression without affecting the protein level of APP.
Gnetin C efficiently ameliorates the cell viability lowered by Aβ42
We next examined cell viability in Aβ42-treated SH-SY5Y cells that were pretreated with 10 or 20 μM of gnetin C, ε-viniferin or resveratrol (Fig. 5) . The cells were pretreated with the biophenol for 1 h and then with 10 μM of Aβ42 for 24 h. Control cells were treated with DMSO during the experiment. Consistent with our previous studies (8, 22) , Aβ42 reduced the cell viability to 36%; however, 10 and 20 μM of gnetin C efficiently (46 and 81%, respectively) ameliorated the toxicity. Gnetin C alone did not affect cell viability up to a concentration of 20 μM (Fig. 1) . Therefore, we used 20 μM gnetin C for the following experiments.
Incidentally, 10 and 20 μM of resveratrol partially (33 and 46%, respectively) improved the toxicity, although ε-viniferin did not.
Gnetin C reduces intracellular Aβ oligomers
To clarify the effects of gnetin C pretreatment on the levels of intracellular Aβ oligomers, we analyzed the generation of Aβ oligomers in whole lysates of cells preincubated with gnetin C (20 μM) for 1 h and then treated with Aβ42 monomer (10 μM) for 24 h. As shown in Fig. 6A and 6B, the gnetin C pretreatment reduced the level of intracellular Aβ oligomers (high molecular weight oligomers, 100-150 kDa) (29, 41) by 65%. An intracellular 15-kDa Aβ oligo- expression without inducing the other secretases (α-and γ-secretases) or their substrate, APP. Since BACE1 together with presenilin-1 (the main part of γ-secretase) produces Aβ monomers from APP (24, 40) , the decline of BACE1 leads to reduce Aβ42 production. Furthermore, gnetin C promotes the synthesis of an Aβ-decomposing enzyme, MMP-14 (18) , although the other Aβ-decomposing enzymes such as NEP (12, 38) , IDE and ECE1 (38) are not increased by gnetin C. Thus, the suppressed BACE1 and the induced MMP-14 expression may be responsible for the decrease of Aβ production and release from the cells.
On the other hand, resveratrol and ε-viniferin unlike gnetin C enhanced α-, β-, or γ-secretase, or Aβ-decomposing enzymes such as NEP, IDE, or ECE1. In particular, resveratrol and ε-viniferin enhanced the expression of α-secretases, ADAM10 or TACE (16) . These mechanisms may comprehensively contribute to the reduced Aβ42 production in the cells challenged with Aβ42. Since gnetin C elevates the levels of both intracellular and extracellular Aβ monomers in cells treated with Aβ42, gnetin C may play roles in inhibition against internalization and oligomerization of exogenous Aβ monomers. Although the detailed mechanisms are not known, these functions can reduce intracellular Aβ accumulation. Indeed, the Aβ oligomers generated in the cells treated with Aβ42 were effectively reduced by gnetin C. Noteworthily, the main size of the Aβ oligomers that were reduced by gnetin C in this study was between 100-150 kDa, similar to that of Aβ assemblies, termed amylospheroids (ASPD, 128 kDa) (25) . The amylospheroids have been shown to cause presynaptic calcium overload by interacting with sodium pumps (specifically, the neuron-specific Na + / K + -ATPase α3 subunit), leading to neurodegeneration (25) . The reduction of such toxic Aβ oligomers may in turn, contribute to the increased cell viability in Aβ-treated cells.
In addition, we found that gnetin C enhanced the expression of MMP-14 even in cells treated with Aβ42. MMP-14 is also reported to degrade both soluble and fibrillar Aβ peptides (18) , and it may play a role in reducing Aβ oligomers in cells challenged with Aβ. This could also explain how gnetin C reduced the Aβ oligomers and ameliorated the cell viability. The underlying mechanisms remain to be clarified in future studies. Gnetin C itself has radical scavenging activity similar to that of ascorbic acid and dl-α-tocopherol (13) . This supports the hypothesis that gnetin C is a helpful agent for attenuating the Aβ-induced oxidative stress, since Aβ generates reactive oxygen species (ROS) in the AD brain (4, 5, 10) . More works will be required to clarify the mechanisms of the protective and/or restorative activities of gnetin C on Aβ-induced damage and apoptosis in neuronal cells. Finally, the clinical and prophylactic efficacy of gnetin C in AD pathologies remains to be evaluated, although melinjo, a plant which is rich in resveratrol dimers including gnetin C (19) , is commonly cultivated and traditionally used as a vegetable in Southeast Asia, such as Indonesia. Interestingly, melinjo extracts are reported to exhibit biological activities, such as anticancer (6), vasculoprotective (17) and antioxidant (32) properties, which may lead to longevity (11) . Gnetin C as well as other melinjo-derived biophenols is free from harmful side effects (35, 36 ), leading to a high level of expectation for its potential use in the prevention and/or treatment of AD. Collectively, gnetin C reduces Aβ production and cells treated with resveratrol or ε-viniferin. Nevertheless, the suppressive effects of resveratrol and ε-viniferin on Aβ42 production are lower than that of gnetin C. Although both gnetin C and ε-viniferin are dimers of trans-resveratrol, they are diastereomers of each other (6) . In general, diastereomers have different physical properties and different chemical activities, which may lead to different biological activities. This study also shows that gnetin C pretreatment effectively improves the deteriorated viability of the ameliorates Aβ-induced neurotoxicity. Possible mechanisms by which gnetin C executes these effects include a decrease in β-site APP-cleavage and an increase in Aβ decomposition through the suppression of BACE1 and the induction of MMP-14, respectively, and are illustrated in Fig. 8 . Also, gnetin C may play a role in reducing both internalization and oligomerization of exogenous Aβ monomers. Reduction of intracellular Aβ oligomers by gnetin C may contribute to the preservation or recovery of neuronal cell viability, which results in protecting the cells from Aβ accumulation. In conclusion, the use of gnetin C could potentially prevent the progression of Aβ-mediated diseases, such as AD.
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